March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Learn why nutrition is so important to HIV+ people, how it is measured, and several ways to stay healthy by eating smarter.
Judith Auerbach, Ph.D., is a public sociologist, independent science and policy consultant, and adjunct professor in the School of Medicine at the University of California, San Francisco (UCSF) who has demonstrated a lifelong commitment to helping women with HIV.